Clinically significant azole cross‐resistance in Candida isolates from HIV‐positive patients with oral candidosis

No abstract is available for this paper.

• Publication year

  1997

• Venue

  AIDS (London)

• Publication date

  1997-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/00002030-199715000-00008PMID 9412702
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Itraconazole cyclodextrin solution: the role of in vitro susceptibility testing in predicting successful treatment of HIV‐related fluconazole‐resistant and fluconazole‐susceptible oral candidosis

  1997cited by this paper
• Clinical response to ketoconazole of HIV-related oral candidosis is predicted by Odds' relative growth method of susceptibility testing.

  1997cited by this paper
• Correlation between rhodamine 123 accumulation and azole sensitivity in Candida species: possible role for drug efflux in drug resistance

  1996cited by this paper
• Mechanisms of resistance to azole antifungal agents in Candida albicans isolates from AIDS patients involve specific multidrug transporters

  1995cited by this paper
• Fluconazole‐resistant candidosis in an HIV cohort

  1994cited by this paper
• Itraconazole cyclodextrin solution--effective treatment for HIV-related candidosis unresponsive to other azole therapy.

  1994cited by this paper
• Multiple dose pharmacokinetics of an oral solution of itraconazole in autologous bone marrow transplant recipients.

  1994cited by this paper
• Fluconazole resistance in Candida glabrata

  1993cited by this paper
• Characterization of an azole-resistant Candida glabrata isolate

  1992cited by this paper
• Azole drug resistance in Candida species.

  1992cited by this paper
• Antifungal susceptibility testing of Candida spp. by relative growth measurement at single concentrations of antifungal agents

  1992influential reference
• Fluconazole resistant candida in AIDS.

  1991cited by this paper
• Candida albicans resistance in AIDS.

  1991cited by this paper
• Fluconazole resistant candida in AIDS.

  1991cited by this paper
• Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals.

  1990cited by this paper
• Gastropathy and ketoconazole malabsorption in the acquired immunodeficiency syndrome (AIDS).

  1988influential reference

• Novel Antimicrobial Compounds from Indigenous Plants and Microbes: An Imminent Resource

  2020cites this paper
• Identification and Testing of Antidermatophytic Oxaborole-6-Benzene Sulphonamide Derivative (OXBS) from Streptomyces atrovirens KM192347 Isolated from Soil

  2020cites this paper
• Detection of antifungal drug-resistant and ERG11 gene mutations among clinical isolates of Candida species isolated from Khartoum, Sudan.

  2020cites this paper
• Impact of Farnesol as a Modulator of Efflux Pumps in a Fluconazole-Resistant Strain of Candida albicans

  2019cites this paper
• Missense mutation in CgPDR1 regulator associated with azole-resistant Candida glabrata recovered from Thai oral candidiasis patients.

  2019cites this paper
• Role of Antifungal Drugs in Combating Invasive Fungal Diseases

  2019cites this paper
• Antifungal Susceptibility of Candida albicans Isolates at a Tertiary Care Hospital in Bulgaria

  2019cites this paper
• Antimicrobial Drug Resistance

  2017influential citation
• In vitro susceptibility of Candida albicans clinical isolates to eight antifungal agents in Ouagadougou (Burkina Faso).

  2017cites this paper
• Species identification and antifungal susceptibility pattern of Candida isolates in cases of vulvovaginal candidiasis

  2016cites this paper
• In Vitro Susceptibilities of Candida albicans Isolates to Antifungal Agents in Tokat, Turkey

  2015cites this paper
• Antimicrobial Compounds

  2014cites this paper
• Diversité génétique d'isolats de Cryptococcus et Candida issus des patients VIH positifs à Yaoundé et étude de leur sensibilité aux antifongiques et aux extraits de plantes

  2014cites this paper
• New Cell Wall-Affecting Antifungal Antibiotics

  2014cites this paper
• Isolation and screening of Streptomyces from local area in Sudan in the presence of amphotericin A and B

  2014cites this paper
• Analysis of strain relatedness using High Resolution Melting in a case of recurrent candiduria

  2013cites this paper
• Azole‐resistant Candida spp. – emerging pathogens?

  2012cites this paper
• Profile of candidiasis in HIV infected patients

  2012cites this paper
• In Vitro Activity of Anidulafungin and Other Agents against Esophageal Candidiasis-Associated Isolates from a Phase 3 Clinical Trial

  2010cites this paper
• The Role of Resistance in Candida Infections: Epidemiology and Treatment

  2009cites this paper
• Effect of amine fluoride-stannous fluoride preparations on oral yeasts in the elderly: a randomised placebo-controlled trial.

  2009cites this paper
• Micafungin: a sulfated echinocandin

  2009cites this paper
• Isolation of antifungal compounds from Gardenia jasminoides.

  2009cites this paper
• CHAPTER 8 – Candida

  2009cites this paper
• In Candida albicans, resistance to flucytosine and terbinafine is linked to MAT locus homozygosity and multilocus sequence typing clade 1.

  2009cites this paper
• Novel Antifungal Antibiotic from Myrothecium cinctum No . 002 I . Taxonomy , Fermentation , Isolation and Physico-chemical Properties

  2008cites this paper
• Susceptibility to Voriconazole, Fluconazole, and Ketoconazole of Yeast Isolated from Patients with Hematological Malignancies

  2008cites this paper
• Biosynthetic studies of fungal diterpene antibiotics

  2007cites this paper
• Isolation and screening of Streptomyces in soil of protected forest areas from the states of Assam and Tripura, India, for antimicrobial metabolites

  2007cites this paper
• Oral candidiasis and oral yeast carriage among institutionalised South African paediatric HIV/AIDS patients

  2007cites this paper
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738

  2006cites this paper
• In vitro antifungal effect of amine fluoride-stannous fluoride combination on oral Candida species.

  2006cites this paper
• Oral health and morbidity--implications of oral infections on the elderly.

  2006cites this paper
• In Vitro Activity and In Vivo Efficacy of Icofungipen (PLD-118), a Novel Oral Antifungal Agent, against the Pathogenic Yeast Candida albicans

  2006cites this paper
• FR220897 and FR220899, Novel Antifungal Lipopeptides from Coleophoma empetri No. 14573

  2006cites this paper
• FR209602 and Related Compounds, Novel Antifungal Lipopeptides from Coleophoma crateriformis No. 738

  2006cites this paper
• FR 207944 , an Antifungal Antibiotic from Chaetomium sp . No . 217 I . Taxonomy , Fermentation , and Biological Properties

  2005cites this paper
• Actinomycetes isolated from lichens: evaluation of their diversity and detection of biosynthetic gene sequences.

  2005cites this paper
• FR207944, an Antifungal Antibiotic from Chaetomium sp. No. 217 I. Taxonomy, Fermentation, and Biological Properties

  2005cites this paper
• Prise en charge diagnostique et thérapeutique des infections à Aspergillus sp. chez le patient immunodéprimé. Recommandations du CHRU de lille - version 4 - novembre 2004

  2005cites this paper
• [Management of aspergillosis in immunocompromised patients. Recommendations of Lille University Hospital--4th version--November 2004].

  2005cites this paper
• Molekulare und immunelektronenmikroskopische Untersuchungen zur Expression von sekretorischen Aspartatproteinasen in einem ex vivo Modell der vaginalen Kandidose und in vivo

  2005cites this paper
• FR227244, a novel antifungal antibiotic from Myrothecium cinctum No. 002 Taxonomy, fermentation, isolation and physico-chemical properties.

  2004cites this paper
• Efficacy of PLD-118, a Novel Inhibitor of Candida Isoleucyl-tRNA Synthetase, against Experimental Oropharyngeal and Esophageal Candidiasis Caused by Fluconazole-Resistant C. albicans

  2004cites this paper
• Impact of real-time fungal susceptibility on clinical practices

  2004cites this paper
• Clinically Promising New Triazoles for Systemic Fungal Infections

  2004cites this paper
• Susceptibility testing of fungi--current status and open questions.

  2003cites this paper
• Microbial natural products as a source of antifungals.

  2003cites this paper
• Patterns of antimicrobial activities from soil actinomycetes isolated under different conditions of pH and salinity

  2003cites this paper
• Antifungal drug resistance of pathogenic fungi.

  2002cites this paper
• Antifungal susceptibility of South African oral yeast isolates from HIV/AIDS patients and healthy individuals.

  2002cites this paper
• Oral candidosis.

  2002cites this paper
• The secreted aspartic proteinases as a new target in the therapy of candidiasis.

  2002cites this paper
• Management of Candida Infections in the Intensive Care Unit

  2002cites this paper
• Voriconazole -- better chances for patients with invasive mycoses.

  2002cites this paper
• Fluconazole and Voriconazole Multidisk Testing ofCandida Species for Disk Test Calibration and MIC Estimation

  2001cites this paper
• Experimentelle Untersuchungen zur Pathogenese und Therapie der oralen Candidiasis bei Immundefizienz

  2001cites this paper
• Oropharyngeal candidiasis in patients with human immunodeficiency virus: correlation of clinical outcome with in vitro resistance, serum azole levels, and immunosuppression.

  2001cites this paper
• Antimicrobial activity of ergokonin A from Trichoderma longibrachiatum

  2001cites this paper
• Cross-Resistance of Clinical Isolates of Candida albicans and Candida glabrata to Over-the-Counter Azoles Used in the Treatment of Vaginitis

  2000cites this paper
• Orale und osophageale Kandidose

  2000cites this paper
• Antimicrobial effects of alpha-MSH peptides.

  2000cites this paper
• Elevated Phenotypic Switching and Drug Resistance ofCandida albicans from Human Immunodeficiency Virus-Positive Individuals prior to First Thrush Episode

  2000cites this paper
• Azole cross-resistance to ketoconazole, fluconazole, itraconazole and voriconazole in clinical Candida albicans isolates from HIV-infected children with oropharyngeal candidosis.

  2000cites this paper
• Antimicrobial effects of α‐MSH peptides

  2000cites this paper
• The mouth and palliative care

  2000cites this paper
• Disseminated cutaneous sporotrichosis in an AIDS patient receiving maintenance therapy with fluconazole for previous cryptococcal meningitis.

  1999cites this paper
• Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans.

  1999cites this paper
• Infection and chronic colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing a novel AmpC beta-lactamase different from that known.

  1999cites this paper
• In vitro antifungal activity of BMS-207147 and itraconazole against yeast strains that are non-susceptible to fluconazole.

  1999cites this paper
• [Controversial points in the treatment of patients with haematologic malignancies complicated with systemic fungal infections].

  1999cites this paper
• Contribution of mutations in the cytochrome P 450 14 α-demethylase ( Erg 11 p , Cyp 51 p ) to azole resistance in Candida albicans

  1999cites this paper
• Fluconazole sensitivities of Candida species isolated from the mouths of terminally ill cancer patients

  1998cites this paper
• Candida Cross Resistance to Azoles

  1998cites this paper
• [New aspects in treatment of systemic mycoses].

  1998cites this paper